Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
Annika Klumpp, MD,
Felix Luessi, MD,
Sinah Engel, MD,
Beate Weidenthaler-Barth, MD,
Detlef Becker, MD,
Stephan Grabbe, MD,
Hadrian Schepler, MD
Affiliations
Annika Klumpp, MD
Department of Dermatology, University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany; Correspondence to: Annika Klumpp, MD, Langenbeckstraße 1, 55131 Mainz, Germany.
Felix Luessi, MD
Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
Sinah Engel, MD
Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
Beate Weidenthaler-Barth, MD
Department of Dermatology, University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany
Detlef Becker, MD
Department of Dermatology, University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany
Stephan Grabbe, MD
Department of Dermatology, University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany
Hadrian Schepler, MD
Department of Dermatology, University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany
